735 A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: initial dose-escalation results

Authors :: Melissa Johnson
Nehal Lakhani
Eugenia Girda
Anthony Olszanski
Lawrence Fong
Hyunsil Han
Kerry Casey
Siyu Li
Jennifer Visich
Dmitris Skokos
Frank Seebach
Israel Lowy
Matthew Fury
Melissa Mathias
Neil Segal
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools